It's Fight Night in New York
FIFA President Revealed Who His Special Guest Will Be for the Final. The...
Zohran Mamdani Just Said This About What Should Happen to ICE
Leftist Empathy Is Not a Superpower
America's Favorite World Cup Fan Just Got an Incredible Dinner Invitation
This Interview Shows Why We Despite the Leftist Media
James Talarico Says He's Inspired by This 'TransQueer Latinx' Theologian, and That'll Play...
Republicans Hang On
Ted Cruz: AI Must Be Driven by Free Markets and Free Speech.
Tucker Carlson Is Done With the Republican Party. Good Riddance.
Immigration Attorney Gets Massive Fine For Filing Fraudulent Asylum Claims
These Antifa Terrorists Are Going To Be Spending Nearly 500 Years in Prison
James Talarico Drops Millions on Ad Campaign Filled With Falsehoods
Mamdani Mourns Death of Journalist Whom IDF Says Was a Hamas Terrorist
PA House Democrats Advance Bill Restricting School Choice Programs
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos